Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Urszula N. Wasko(Columbia University Irving Medical Center), Jingjing Jiang(Revolution Medicines (United States)), Tanner C. Dalton(Columbia University Irving Medical Center), Álvaro Curiel‐García(Columbia University Irving Medical Center), A. Cole Edwards(University of North Carolina at Chapel Hill), Yingyun Wang(Revolution Medicines (United States)), Bianca J. Lee(Revolution Medicines (United States)), Margo Orlen(University of Pennsylvania), Sha Tian(Memorial Sloan Kettering Cancer Center), Clint A. Stalnecker(University of North Carolina at Chapel Hill), Kristina Drizyte‐Miller(University of North Carolina at Chapel Hill), Marie Ménard(Revolution Medicines (United States)), Julien Dilly(Harvard University), Stephen A. Sastra(Columbia University Irving Medical Center), Carmine F. Palermo(Columbia University Irving Medical Center), Marie C. Hasselluhn(Columbia University Irving Medical Center), Amanda R. Decker-Farrell(Columbia University Irving Medical Center), Stephanie Chang(Revolution Medicines (United States)), Lingyan Jiang(Revolution Medicines (United States)), Xing Wei(Revolution Medicines (United States)), Yu Chi Yang(Revolution Medicines (United States)), Ciara Helland(Revolution Medicines (United States)), Haley Courtney(Revolution Medicines (United States)), Yevgeniy Gindin(Revolution Medicines (United States)), Karl Muonio(Revolution Medicines (United States)), Ruiping Zhao(Revolution Medicines (United States)), Samantha B. Kemp(University of Pennsylvania), Cynthia Clendenin(University of Pennsylvania), Rina Sor(University of Pennsylvania), William P. Vostrejs(University of Pennsylvania), Priya S. Hibshman(University of North Carolina at Chapel Hill), Amber M. Amparo(University of North Carolina at Chapel Hill), Connor J. Hennessey(Harvard University), Matthew G. Rees(Broad Institute), Melissa M. Ronan(Broad Institute), Jennifer A. Roth(Broad Institute), Jens Brodbeck(Revolution Medicines (United States)), Lorenzo Tomassoni(Columbia University Irving Medical Center), Basil Bakir(Columbia University Irving Medical Center), Nicholas D. Socci(Memorial Sloan Kettering Cancer Center), Laura E. Herring(University of North Carolina at Chapel Hill), Natalie K. Barker(University of North Carolina at Chapel Hill), Junning Wang(Harvard University), James M. Cleary(Harvard University), Brian M. Wolpin(Harvard University), John A. Chabot(Columbia University), Michael D. Kluger(Columbia University), Gulam A. Manji(Columbia University Irving Medical Center), Kenneth Y. Tsai(Moffitt Cancer Center), Miroslav Sekulic(Columbia University Irving Medical Center), Stephen M. Lagana(Columbia University Irving Medical Center), Andrea Califano(Johns Hopkins University), Elsa Quintana(Revolution Medicines (United States)), Zhengping Wang(Revolution Medicines (United States)), Jacqueline A.M. Smith(Revolution Medicines (United States)), Matthew Holderfield(Revolution Medicines (United States)), David Wildes(Revolution Medicines (United States)), Scott W. Lowe(Memorial Sloan Kettering Cancer Center), Michael A. Badgley(Columbia University Irving Medical Center), Andrew J. Aguirre(Broad Institute), Robert H. Vonderheide(Parker Institute for Cancer Immunotherapy), Ben Z. Stanger(University of Pennsylvania), Timour Baslan(University of Pennsylvania), Channing J. Der(University of North Carolina at Chapel Hill), Mallika Singh(Revolution Medicines (United States)), Kenneth P. Olive(Columbia University Irving Medical Center)
Cited by 5Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis